| ISIN | LU1225778213 |
|---|---|
| Valor Number | 27986802 |
| Bloomberg Global ID | |
| Fund Name | Pictet - Longevity -Z EUR |
| Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
| Fund Provider | Pictet Asset Management S.A. |
| Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
| Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The investment objective of the fund is to increase the value of your investment while seeking to achieve a positive social impact. The Fund aims to achieve long-term capital growth by investing in companies that support and enhance longevity, as it pertains to individuals and society. |
| Peculiarities |
| Current Price * | 383.79 EUR | 04.12.2025 |
|---|---|---|
| Previous Price * | 383.00 EUR | 03.12.2025 |
| 52 Week High * | 468.67 EUR | 07.02.2025 |
| 52 Week Low * | 358.79 EUR | 09.04.2025 |
| NAV * | 383.79 EUR | 04.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 449,467,945 | |
| Unit/Share Assets *** | 39,886,135 | |
| Trading Information SIX | ||
| YTD Performance | -12.08% |
31.12.2024 - 04.12.2025
31.12.2024 04.12.2025 |
|---|---|---|
| YTD Performance (in CHF) | -12.70% |
31.12.2024 - 04.12.2025
31.12.2024 04.12.2025 |
| 1 month | +1.37% |
04.11.2025 - 04.12.2025
04.11.2025 04.12.2025 |
| 3 months | +2.10% |
04.09.2025 - 04.12.2025
04.09.2025 04.12.2025 |
| 6 months | -2.57% |
04.06.2025 - 04.12.2025
04.06.2025 04.12.2025 |
| 1 year | -14.37% |
04.12.2024 - 04.12.2025
04.12.2024 04.12.2025 |
| 2 years | +2.74% |
04.12.2023 - 04.12.2025
04.12.2023 04.12.2025 |
| 3 years | +3.00% |
05.12.2022 - 04.12.2025
05.12.2022 04.12.2025 |
| 5 years | +17.44% |
04.12.2020 - 04.12.2025
04.12.2020 04.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Boston Scientific Corp | 7.20% | |
|---|---|---|
| Intuitive Surgical Inc | 5.53% | |
| Lonza Group Ltd | 5.46% | |
| Danaher Corp | 5.34% | |
| AstraZeneca PLC | 4.94% | |
| Eli Lilly and Co | 4.74% | |
| Agilent Technologies Inc | 4.45% | |
| Garmin Ltd | 4.09% | |
| Steris PLC | 3.93% | |
| Haleon PLC | 3.68% | |
| Last data update | 31.10.2025 | |
| TER *** | 0.13% |
|---|---|
| TER date *** | 31.03.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.00% |
| Ongoing Charges *** | 0.11% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |